Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $25.8450 (-2.84%) ($25.7900 - $26.7400) on Wed. Sep. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.3% (three month average) | RSI | 30 | Latest Price | $25.8450(-2.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.5% a day on average for past five trading days. | Weekly Trend | HALO declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(48%) IWC(45%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.15% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-13%) EDOC(-4%) DRIV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.15% (StdDev 2.3%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $21.95(-15.07%) | Resistance Level | $27.64 | 5 Day Moving Average | $26.96(-4.14%) | 10 Day Moving Average | $27.18(-4.91%) | 20 Day Moving Average | $27.64(-6.49%) | To recent high | -12.7% | To recent low | 4.5% | Market Cap | $3.532b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |